# NEO-RT (NCT06205485)

> Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

No report yet. It can be ordered.

- Drugs tested: FOLFOX; CAPOX
- Indication: early rectal cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06205485
- Phase: PHASE3
- Status: RECRUITING
- Sponsor: Canadian Cancer Trials Group
- Conditions: Rectal Cancer
- Interventions: Leucovorin; Oxaliplatin; Fluoruracil; Capecitabine; Radiation
- Enrollment: 250
- Primary outcome: Clinical response rate upon re-staging
- Primary outcome: Quality of Life defined using the LARS score

## Indexed commentary on NEO-RT so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 20

## Order

Standard, $1,250 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=neo-rt-nct06205485

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT06205485", "email": "<work email>"}; the inbox owner confirms by the emailed link.